8-K ·Filed Jul 22, 2026

INSP

Inspire Medical Systems, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago SEC0001609550-26-000038
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

This is a routine board retirement with no financial or operational implications. Monitor for the announcement of a replacement director, but no trading action is warranted based on this filing alone.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
INSP ▲ +22.40% at T+20d
NEUTRAL call ✓ call won +22.40% · α vs SPY +19.50% · entry $50.40 → $61.69
Next anchor: T+60d in 13d
Latest observation: T+49 +49.40% FF3 residual α
Entry anchored
Jul 22, 07:09 AM ET
via exchange tick
T+1d
+0.81%
call +0.81% · α +2.05%
$50.81
settled 2mo ago
T+5d
+1.33%
call +1.33% · α +3.73%
$51.07
settled 2mo ago
T+20d
+22.40%
call +22.40% · α +19.50%
$61.69
settled 6w ago
T+60d
—
call — · α —
—
in 13d

Price Chart

Loading chart...

Executive Summary

Inspire Medical Systems announced the retirement of board member Casey M. Tansey, effective July 30, 2026, after more than 18 years of service. The departure is amicable and not due to any disagreement with the company. A replacement is expected to be named in the near future. This is a routine board transition with no material impact on operations or strategy.

Key Facts

  • Casey M. Tansey notified the Board of his retirement on July 16, 2026, effective July 30, 2026.
  • Tansey's retirement is not the result of any disagreement with the company or its operations, policies, or practices.
  • Tansey served on the Board for over 18 years, representing U.S. Venture Partners since leading the Series A financing in November 2007.
  • The company expects to announce the appointment of a new director in the near future.
  • No financial figures, compensation details, or changes to executive leadership were disclosed.

Financial Impact

No financial impact from this routine board retirement.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
36% bullish (25 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001609550-26-000038
Document: caseytanseydeparturepr.htm0001609550-26-000038
Document: 0001609550-26-000038-index-headers.html0001609550-26-000038
Document: 0001609550-26-000038-index.html0001609550-26-000038
Document: 0001609550-26-000038.txt0001609550-26-000038
8 reports for INSP
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for INSP — sortable, filterable
TypeNow
Jul 27, 2026
9w ago
3
NEUTRAL ★ 1/10
$51.97 $61.07▲ +17.51%▲ +14.13%$69.97 (+34.64%)
Jul 24, 2026
10w ago
8-K
NEUTRAL ★ 2/10
$50.93 $61.47▲ +20.70%▲ +17.40%$69.97 (+37.38%)
Jul 22, 2026
10w ago
8-K
NEUTRAL ★ 2/10
$50.40 $61.69▲ +22.40%▲ +19.50%$69.97 (+38.83%)
Jul 6, 2026
12w ago
Press Release
BEARISH ★ 6/10
$49.45 $50.21▼ −1.54%▼ −2.10%$69.97 (−41.50%)
Jun 11, 2026
16w ago
Institutional Cluster
NEUTRAL ★ 5/10
$42.70 $51.76▲ +21.22%▲ +19.44%$69.97 (+63.86%)
May 8, 2026
21w ago
144
NEUTRAL ★ 2/10
$43.35 $42.21▼ −2.63%▼ −2.33%$69.97 (+61.41%)
Apr 6, 2026
25w ago
Press Release
NEUTRAL ★ 3/10
$54.14 $54.84▲ +1.29%▼ −7.69%$69.97 (+29.24%)
Mar 20, 2026
28w ago
DEFA14A
NEUTRAL ★ 2/10
$53.72 $56.97▲ +6.05%▼ −3.27%$69.97 (+30.25%)
Showing 8 of 8

US Market Status

Market Closed — Opens Mon (38h 4m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access